AAAAAA
Results:
1-24
|
Results: 24
Authors:
EDELSTAM G
LECANDER I
LARSSON B
ASTEDT B
Citation: G. Edelstam et al., FIBRINOLYSIS IN THE PERITONEAL-FLUID DURING ADHESIONS, ENDOMETRIOSIS AND ONGOING PELVIC INFLAMMATORY DISEASE, Inflammation, 22(4), 1998, pp. 341-351
Authors:
BORGFELDT C
CASSLEN B
LIU CL
HANSSON S
LECANDER I
ASTEDT B
Citation: C. Borgfeldt et al., HIGH TISSUE CONTENT OF UROKINASE PLASMINOGEN-ACTIVATOR (U-PA) IS ASSOCIATED WITH HIGH STROMAL EXPRESSION OF U-PA MESSENGER-RNA IN POORLY DIFFERENTIATED SEROUS OVARIAN-CARCINOMA, International journal of cancer, 79(6), 1998, pp. 588-595
Authors:
BRUSE C
BERGQVIST A
CARLSTROM K
FIANUJONASSON A
LECANDER I
ASTEDT B
Citation: C. Bruse et al., FIBRINOLYTIC FACTORS IN ENDOMETRIOTIC TISSUE, ENDOMETRIUM, PERITONEAL-FLUID, AND PLASMA FROM WOMEN WITH ENDOMETRIOSIS AND IN ENDOMETRIUM AND PERITONEAL-FLUID FROM HEALTHY WOMEN, Fertility and sterility, 70(5), 1998, pp. 821-826
Authors:
ASTEDT B
LINDOFF C
Citation: B. Astedt et C. Lindoff, PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITORS IN PLASMAOF PREMATURE AND TERM NEWBORNS, Acta paediatrica, 86(1), 1997, pp. 111-113
Authors:
LINDOFF C
INGEMARSSON I
MARTINSSON G
SEGELMARK M
THYSELL H
ASTEDT B
Citation: C. Lindoff et al., PREECLAMPSIA IS ASSOCIATED WITH A REDUCED RESPONSE TO ACTIVATED PROTEIN-C, American journal of obstetrics and gynecology, 176(2), 1997, pp. 457-460
Authors:
LINDOFF C
PETERSON F
LECANDER I
MARTINSSON G
ASTEDT B
Citation: C. Lindoff et al., TRANSDERMAL ESTROGEN REPLACEMENT THERAPY - BENEFICIAL-EFFECTS ON HEMOSTATIC RISK-FACTORS FOR CARDIOVASCULAR-DISEASE, Maturitas, 24(1-2), 1996, pp. 43-50
Authors:
BILLSTROM A
KINNBY B
LECANDER I
ASTEDT B
Citation: A. Billstrom et al., PRODUCTION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 IN HUMAN PERIPHERAL-BLOOD MONOCYTES UP-REGULATED IN-VITRO BY THE QUINOLINE-3-CARBOXAMIDE, LINOMIDE, Fibrinolysis, 10(5-6), 1996, pp. 277-283
Authors:
LINDGREN A
LINDOFF C
NORRVING B
ASTEDT B
JOHANSSON BB
Citation: A. Lindgren et al., TISSUE-PLASMINOGEN ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 INSTROKE PATIENTS, Stroke, 27(6), 1996, pp. 1066-1071
Authors:
ASTEDT B
LECANDER I
MARTINSSON G
KISO U
HENSCHEN A
Citation: B. Astedt et al., ON THE AFFINITY BETWEEN THE PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 AND APOLIPOPROTEIN A(1), Scandinavian journal of clinical & laboratory investigation, 56(6), 1996, pp. 491-496
Authors:
KINNBY B
MATSSON L
ASTEDT B
Citation: B. Kinnby et al., AGGRAVATION OF GINGIVAL INFLAMMATORY SYMPTOMS DURING PREGNANCY-ASSOCIATED WITH THE CONCENTRATION OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 (PAI-2) IN GINGIVAL FLUID, Journal of Periodontal Research, 31(4), 1996, pp. 271-277
Authors:
EDLUND M
ANDERSSON K
RYBO G
LINDOFF C
ASTEDT B
VONSCHOULTZ B
Citation: M. Edlund et al., REDUCTION OF MENSTRUAL BLOOD-LOSS IN WOMEN SUFFERING FROM IDIOPATHIC MENORRHAGIA WITH A NOVEL ANTIFIBRINOLYTIC DRUG (KABI-2161), British journal of obstetrics and gynaecology, 102(11), 1995, pp. 913-917
Authors:
KINNBY B
ASTEDT B
CASSLEN B
Citation: B. Kinnby et al., REDUCTION OF PAI-2 PRODUCTION IN CULTURED HUMAN PERIPHERAL-BLOOD MONOCYTES BY ESTRADIOL AND PROGESTERONE - NO EFFECT ON T-PA, U-PA AND PAI-1, Fibrinolysis, 9(3), 1995, pp. 152-156
Authors:
ASTEDT B
BILLSTROM A
LECANDER I
Citation: B. Astedt et al., UROKINASE-PRODUCING TUMOR-GROWTH IN SCID MICE INHIBITED BY RECOMBINANT PAI-2, Fibrinolysis, 9(3), 1995, pp. 175-177
Authors:
BEKASSY Z
IOSIF CS
ASTEDT B
Citation: Z. Bekassy et al., MINIMAL LASER CONIZATION DURING PREGNANCY, Lasers in medical science, 10(2), 1995, pp. 131-136
Authors:
ASTEDT B
Citation: B. Astedt, ANTENATAL DRUGS AFFECTING VITAMIN-K STATUS OF THE FETUS AND THE NEWBORN, Seminars in thrombosis and hemostasis, 21(4), 1995, pp. 364-370
Authors:
BILLSTROM A
HARTLEYASP B
LECANDER I
BATRA S
ASTEDT B
Citation: A. Billstrom et al., THE UROKINASE INHIBITOR P-AMINOBENZAMIDINE INHIBITS GROWTH OF A HUMANPROSTATE TUMOR IN SCID MICE, International journal of cancer, 61(4), 1995, pp. 542-547
Authors:
LINDOFF C
PETERSSON F
SAMSIOE G
ASTEDT B
Citation: C. Lindoff et al., TREATMENT WITH A GNRH ANALOG - EFFECTS ON HEMOSTATIC RISK-FACTORS FORTHROMBOEMBOLIC DISEASE, International journal of fertility and menopausal studies, 39(3), 1994, pp. 133-139
Authors:
CASSLEN B
BOSSMAR T
LECANDER I
ASTEDT B
Citation: B. Casslen et al., PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITORS IN BLOOD AND TUMOR FLUIDS OF PATIENTS WITH OVARIAN-CANCER, European journal of cancer, 30A(9), 1994, pp. 1302-1309
Authors:
OLOFSSON P
ASTEDT B
Citation: P. Olofsson et B. Astedt, RENAL-FUNCTION AND URINARY UROKINASE IN HYPERTENSIVE AND DIABETIC PREGNANCIES, Journal of perinatal medicine, 22(3), 1994, pp. 181-188
Authors:
LINDOFF C
ASTEDT B
Citation: C. Lindoff et B. Astedt, PLASMINOGEN-ACTIVATOR OF UROKINASE-TYPE AND ITS INHIBITOR OF PLACENTAL TYPE IN HYPERTENSIVE PREGNANCIES AND IN INTRAUTERINE GROWTH-RETARDATION - POSSIBLE MARKERS OF PLACENTAL FUNCTION, American journal of obstetrics and gynecology, 171(1), 1994, pp. 60-64
Authors:
ASTEDT B
CASSLEN B
LECANDER I
NILSSON L
NORGREN L
Citation: B. Astedt et al., REBOUND INCREASE OF PAI-1 FOLLOWING LOCAL INTRAARTERIAL RT-PA INFUSION, A POSSIBLE CAUSE OF REOCCLUSION, Blood coagulation & fibrinolysis, 4(4), 1993, pp. 563-567
Authors:
LINDOFF C
PETERSSON F
LECANDER I
MARTINSSON G
ASTEDT B
Citation: C. Lindoff et al., PASSAGE OF THE MENOPAUSE IS FOLLOWED BY HEMOSTATIC CHANGES, Maturitas, 17(1), 1993, pp. 17-22
Authors:
LINDOFF C
RYBO G
ASTEDT B
Citation: C. Lindoff et al., TREATMENT WITH TRANEXAMIC ACID DURING PREGNANCY, AND THE RISK OF THROMBOEMBOLIC COMPLICATIONS, Thrombosis and haemostasis, 70(2), 1993, pp. 238-240
Authors:
LINDOFF C
LECANDER I
ASTEDT B
Citation: C. Lindoff et al., FIBRINOLYTIC COMPONENTS IN INDIVIDUAL CONSECUTIVE PLASMA SAMPLES DURING NORMAL-PREGNANCY, Fibrinolysis, 7(3), 1993, pp. 190-194
Risultati:
1-24
|